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Abstract
Cardiovascular magnetic resonance (CMR) is an established non-invasive technique to comprehensively assess
cardiovascular structure and function in a variety of acquired and inherited cardiac conditions. A significant amount
of the neck, thorax and upper abdomen are imaged at the time of routine clinical CMR, particularly in the initial
multi-slice axial and coronal images. The discovery of unsuspected disease at the time of imaging has ethical, financial
and medico-legal implications. Extra-cardiac findings at the time of CMR are common, can be important and can
change clinical management. Certain patient groups undergoing CMR are at particular risk of important extra-cardiac
findings as several of the cardiovascular risk factors for atherosclerosis are also risk factors for malignancy. Furthermore,
the presence of certain extra-cardiac findings may contribute to the interpretation of the primary cardiac pathology as
some cardiac conditions have multi-systemic extra-cardiac involvement. The aim of this review is to give an overview of
the type of extra-cardiac findings that may become apparent on CMR, subdivided by anatomical location. We focus on
normal variant anatomy that may mimic disease, common incidental extra-cardiac findings and important imaging signs
that help distinguish sinister pathology from benign disease. We also aim to provide a framework to the approach and
potential further diagnostic work-up of incidental extra-cardiac findings discovered at the time of CMR. However, it is
beyond the scope of this review to discuss and determine the clinical significance of extracardiac findings at CMR.
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Background
Cardiovascular magnetic resonance (CMR) is an estab-
lished non-invasive technique to comprehensively assess
cardiovascular structure and function in a variety of
acquired and inherited cardiac conditions [1–4]. Although
the key components of a CMR study are acquired in
specific imaging planes orientated along the axes of the
heart, initial axial and occasionally coronal images of the
thorax and upper abdomen are also acquired to help plan
the study. Inevitably, this leads to imaging a significant
volume of the patient beyond the target organ of interest,
which may reveal extra-cardiac pathology (Fig. 1). A
recent systematic review and meta-analysis of 12 studies
including data from 7,062 patients demonstrated a pooled
prevalence of incidental extra-cardiac findings of 35 %,
with major incidental extra-cardiac findings in 12 % [5].
Extra-cardiac findings resulted in a change in manage-
ment in 1 % of patients undergoing CMR [5], which is of
particular importance to large volume CMR centres. The
clinical use of CMR is growing year upon year, and the
burden of extra-cardiac findings identified at the time of
CMR is only likely to get larger as we image older individ-
uals with multiple comorbidities. Furthermore, a large
proportion of patients undergo clinical CMR for the
assessment of ischaemic heart disease and some of the
risk-factors for atherosclerosis (e.g. smoking, obesity,
physical inactivity) are also recognized risk-factors for a
variety of malignancies. The discovery of unsuspected
disease at the time of imaging has ethical, financial and
medico-legal implications [6–8]. However, given the
* Correspondence: C.Bucciarelli-Ducci@bristol.ac.uk
1Cardiovascular Magnetic Resonance Unit, NIHR Bristol Cardiovascular
Biomedical Research Unit, Bristol Heart Institute, University of Bristol, Bristol,
UK
5Department of Cardiology, Bristol Royal Infirmary, University Hospitals Bristol
NHS Foundation Trust, Upper Maudlin Street, Bristol BS2 8HW, UK
Full list of author information is available at the end of the article
© 2016 Rodrigues et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Rodrigues et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:26 
DOI 10.1186/s12968-016-0246-1
incidental nature of the findings and the consequent
non-dedicated imaging and tissue characterization, not in-
frequently these findings require additional confirmatory
imaging. Furthermore, the presence of certain extra-
cardiac findings can significantly contribute to the inter-
pretation of the primary cardiac pathology as some
cardiac conditions have multi-systemic involvement. For
example, the discovery of mediastinal adenopathy and
interstitial lung disease in an appropriate anatomical dis-
tribution would increase the likelihood of cardiac findings
suggestive of cardiac sarcoidosis (Fig. 2). Depending on
the institution, CMR examinations may be reported by
Cardiologists, Radiologists or a combination thereof.
Regardless of the specialty of the reporting doctor, it is
clear that proper interpretation of clinical CMR studies
requires a thorough understanding of cross-sectional anat-
omy and familiarity with normal anatomical variants,
common and important pathology in the organs beyond
the heart captured within the field of view of the CMR
study. The importance of incidental non-cardiovascular
findings has been recognized in the recent update to the
European Association of Cardiovascular Imaging core
syllabus for the European CMR certification exam [9, 10].
The key topics in the syllabus are detailed in Table 1.
A variety of studies have previously explored the preva-
lence and clinical relevance of extra-cardiac findings.
However, the aim of this review is to give an overview of
the type of extra-cardiac findings that may become appar-
ent at CMR, subdivided by anatomical location. We focus
on normal variant anatomy that may mimic disease,
common incidental extra-cardiac findings and important
imaging signs that help distinguish sinister pathology from
benign disease. We also aim to provide a framework
to the approach and potential further diagnostic work-
up of incidental extra-cardiac findings discovered at
the time of CMR. This review cannot possibly equip
Cardiologists who report CMR with specialist radi-
ology training and is not a substitute to seeking expert
Radiology input where necessary, but simply aims to
provide an overview of some of the elements of radio-
logical interpretation of extra-cardiac findings to try
to avoid their misinterpretation, or missing them all
together.
Neck
Localiser images and cross sectional anatomical sequences,
e.g. axial black blood imaging, will often demonstrate a por-
tion of the neck and superior mediastinum. The main
organ of interest imaged in this region in terms of extra-
cardiac findings is the thyroid gland. It is an important
organ because thyroid abnormalities are common. Supra-
clavicular and cervical adenopathy may also be demon-
strated and the topic of pathological lymph nodal disease is
discussed in the Mediastinum section of this review.
Normal variant anatomy
The thyroid gland usually has two lobes joined in the
midline by the isthmus. An additional pyramidal lobe
can arise superiorly from the isthmus and, if present, is
usually located deep to the medial border of the strap
muscles of the neck, overlying laryngeal cartilage [11]. It
should not be misinterpreted as cervical adenopathy.
Fig. 1 a to d Examples of the routine axial black blood images of the neck, thorax and upper abdomen acquired at the time of CMR (Cranial to
Caudal). e to h Examples of the routine coronal bright blood images of the neck, thorax and upper abdomen acquired at the time of CMR
(Anterior to Posterior)
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Common pathology
The most common thyroid pathology is the diffuse goitre.
Its prevalence is greatest in pre-menopausal women and
has a female preponderance (women: men = 4:1) [12] but
prevalence decreases with age. On the contrary, the fre-
quency of thyroid nodules increases with age, with the
prevalence of clinically apparent thyroid nodules demon-
strated in 6.4 % of women and 1.5 % of men aged >60 years
old in a study of 5234 subjects [13]. Both these thyroid
pathologies have been described in previous studies inves-
tigating the prevalence of extra-cardiac findings at the
time of CMR [14–16].
Important imaging findings
Whenever thyroid enlargement is detected, interrogat-
ing the available images for evidence of local mass effect is
important. The position and calibre of the trachea should
be assessed. Tracheal deviation (Fig. 3) and tracheal com-
pression are important findings to mention in the clinical
report. Indeed, they may even be implicated in the
patient’s symptoms if they suffer from breathlessness.
Defining the inferior extent of the enlarged thyroid gland
is important. Significant retrosternal extension of the
thyroid should be mentioned in a report as it hinders
further evaluation of that portion of the thyroid with
ultrasound, which is often the modality of choice for
thyroid pathology.
Table 1 2013 EACVI Core Syllabus for European CMR
certification examination – adapted from references [9] and [10]
9. Incidental (non-cardiovascular) findings
9.1. Neck including normal anatomy
1/ Thyroid nodules
2/ Adenopathy
9.2. Thorax including normal anatomy
1/ Lung (airspace disease, mass)
2/ Pleura (effusion, neoplasm)
3/ Mediastinum
▪ Oesophagus (hernia, mass, dilatation/thickening)
▪ Solid & cystic masses, adenopathy
4/ Bone (fracture, neoplasm, infection)
5/ Chest wall mass (breast, axilla)
9.3. Abdomen including normal anatomy
1/ Liver (cyst/haemangioma, mass, parenchymal disease)
2/ Kidney (cyst, mass, hydronephrosis, parenchymal disease)
3/ Adrenal mass
4/ Spleen (size, lesion)
5/ Other
▪ Gallstones/cholecystitis
▪ Ascites
Fig. 2 CMR performed in a patient with bifasicular block and transient 2:1 second degree atrio-ventricular block. Short-axis LV cine images revealed
global LV systolic impairment with an ejection fraction of 31 %. There is evidence of aorto-pulmonary (a), para-tracheal (a and b) and subcarinal (c)
lymphadenopathy (solid white arrows) on axial black blood imaging. There is also subtle parenchymal lung infiltrate (solid red arrows) in the midzones
(b and c) on axial black blood images. The short axis magnitude late gadolinium enhancement images (d) reveal septal mid-wall and patchy lateral
wall replacement fibrosis (dashed white arrows). Together, the cardiac and extra-cardiac findings, in the clinical context are consistent with cardiac and
pulmonary sarcoidosis
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The main concern regarding an incidental thyroid lesion
at the time of CMR is whether it represents malignant dis-
ease. However, the images of the neck acquired at the time
of CMR are usually very limited preliminary images and it
is often not possible to answer this question. One of the
reasons why magnetic resonance imaging (MRI) is unable
to distinguish benign from malignant disease is because
the spatial resolution of the images is insufficient to re-
solve some of the features associated with malignancy
that may be demonstrated by ultrasound (e.g. micro-
calcifications, intra-lesional vascularity and lobulated /
irregular margins) [17]. Furthermore, both malignant
and benign thyroid nodules have overlapping tissue
characteristics and may both result in iso-intense T1
weighted and hyper-intense T2 weighted signal return
[18]. Although nodule size only has a limited correl-
ation with malignant potential, thyroid malignancies
<2 cm have been reported to have a 99.9 % 10-year sur-
vival rate and failure to diagnose these lesions is un-
likely to affect morbidity and mortality [19, 20]. MRI
may underestimate the size of thyroid nodules relative
to ultrasound, but it is reasonable to use MRI-derived
measurements in risk stratification [21].
Further investigations
The most recent American College of Radiology White
Paper on the management of incidental thyroid nodules
detected at MRI advises, in the absence of suspicious
ancillary findings such as abnormal local lymph nodes
and/or invasion of local tissues by the thyroid nodule, a
cut-off of ≥1 cm in subjects <35 years old as a threshold
to further investigation with ultrasound and a cut-off of
≥1.5 cm in subjects ≥35 years old [17]. The imaging mo-
dality of choice for further characterization is dedicated
ultrasound, which affords the opportunity of simultan-
eous fine needle aspiration (FNA) as appropriate. Sug-
gesting FNA correlation purely on the basis of the MRI
images should be avoided because, although FNA is a
minimally invasive procedure, the inability of cytology to
definitively establish a benign diagnosis in a proportion
of non-malignant nodules will expose a substantial num-
ber of patients to repeat biopsy or even lead to surgical
excision of benign thyroid disease due to indeterminate
cytological results [17].
Interpreting incidental thyroid lesions found at CMR
may require liaising with the referring clinician to iden-
tify any specific thyroid disease risk factors (e.g. family
history of thyroid or endocrine malignancy, previous
neck irradiation etc.). Reviewing any previous ultrasound
imaging and cross-sectional imaging is good practice
and, if any diagnostic doubt, seeking the opinion of a
Head and Neck Radiologist would be prudent.
Mediastinum
Superior, anterior, middle and posterior components of the
mediastinum are visualized on the axial cross-sectional se-
quences usually acquired to plan the subsequent specific
cardiac cines and images.
Normal variant anatomy
Thoracic lymph nodes are a common extra-cardiac find-
ing at CMR [5]. They are readily identified as discrete
ovoid areas of soft tissue signal return within thoracic
fat. Normal lymph nodes have characteristic morphology
with a fatty hilum (Fig. 4a). When measuring lymph
node dimensions, by convention, the short-axis diameter
should be quoted and not the maximum dimension of
the node (Fig. 4b). Generally, the upper limit of normal-
ity for mediastinal lymph nodes in terms of size is
10 mm in short-axis diameter [22–25]. However, there is
variation in thoracic lymph node size depending on loca-
tion, with a tendency for upper paratracheal nodes to be
smaller at 7-8 mm [22, 23, 26]. Retrocrural and peri-
diaphragmatic nodes normally measure up to 6 mm and
5 mm respectively [27, 28]. However, it should be re-
membered that the axial black blood imaging often has a
slice thickness of >5 mm, which may preclude accurate
nodal size measurements.
Fig. 3 Axial black blood imaging of the neck (a) and coronal bright blood imaging (b) demonstrate homogeneous enlargement of the right lobe
of thyroid gland (solid white arrows). There is local mass effect on the trachea with a degree of contralateral displacement and minor tracheal
narrowing (*)
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The thymus gland is a normal anterior mediastinal
structure in children and young adults that should not be
mistaken for an abnormal anterior mediastinal mass. It
has a characteristic bi-lobed shape and convex margins
which become concave with age [29]. Over time, the thy-
mus gland undergoes fatty involution and is absent on im-
aging in 50 % of patients over 40 years old [30]. Thymic
reactivation (Fig. 5) can occur following severe illness and
may account for apparent normal thymic tissue in older
individuals. However, in this scenario a thymic malignancy
also needs to be considered.
The pericardial recesses are important mimics of
lymphadenopathy and distinguishing characteristics in-
clude fluid signal, a beak-like shape, lack of mass effect
and contiguity with the pericardium [31].
Comprehensive discussion of normal variant cardiovas-
cular anatomy is beyond the scope of this review but indi-
viduals reporting CMR studies should be familiar with
normal anatomical variations in cardiac position and situs,
aortic arch anatomy, aberrant superior mediastinal arterial
anatomy and anomalous systemic and pulmonary venous
drainage.
Common pathology
Thoracic lymphadenopathy is a common extra-cardiac
finding at the time of CMR. Numerous pathologies can
cause thoracic lymphadenopathy and if identified it
should prompt a comprehensive review for the potential
aetiology. Causes of benign lymph node enlargement in-
clude pulmonary infection, congestive heart failure [32],
pulmonary fibrosis [33] and pneumoconioses [34]. Bilat-
eral symmetrical hilar and mediastinal node enlargement
in a young adult is most often due to sarcoidosis, al-
though lymphoma is an important differential diagnosis.
Lymphoma often involves the mediastinum and can co-
alesce to form large confluent mediastinal masses [35]
(Fig. 6). Malignancies that commonly metastasize to the
thoracic lymph nodes include lung, breast, head and
neck, melanoma, gastrointestinal and genitourinary car-
cinomas [36] and evidence for these may be present on
extracardiac images or preceding investigations.
Mediastinal masses are an uncommon but important
consideration when reviewing the extra-cardiac structures,
and if detected a Radiological opinion should be sought.
Common anterior mediastinal neoplasms include thym-
oma, lymphoma or teratoma. The most common poster-
ior mediastinal masses include lymphadenopathy and
neurogenic tumours such as schwannomas and neuro-
fibromas [37]. Extramedullary haematopoeisis is relatively
uncommon but may be seen more frequently in centres
where T2* MRI is used for assessment of myocardial and
hepatic iron loading in, for example, thalassaemia patients
(Fig. 7). A frequent incidental finding that may mimic an
inferior posterior mediastinal mass is a hiatus hernia. This
can be readily identified as a structure contiguous with
the alimentary tract, on initial axial and/or coronal images,
and may contain a gas/fluid level. Acid reflux from a hia-
tus hernia can sometimes be responsible for the symptoms
in patients referred for investigation of atypical angina
Fig. 5 Axial black blood imaging of the superior mediastinum in a
20 year old male patient who had recently suffered from a severe
pneumonia complicated with myocarditis. The anterior mediastinal
soft tissue (solid white arrows) detected at the time of CMR was felt
too prominent to be dismissed as normal residual thymus and given
the clinical history the diagnosis of thymic reactivation was made
Fig. 4 Axial black blood imaging of the thorax demonstrating a morphologically normal, ovoid left axillary lymph node (a) with fatty hilum (*).
By convention, lymph node size (b) is measured in the short-axis (dashed black line)
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and, particularly in the case of a negative stress CMR test,
it should be excluded.
Important imaging findings
The most common dilemma when reviewing the medias-
tinum on any imaging modality is trying to determine
whether the discernible lymph nodes are pathological.
The loss of the normal ovoid shape, with a more rounded
configuration, and obliteration of the normal fatty hilum
are findings that suggest the lymph node is abnormal. The
short-axis size cut-off values can be useful but it should be
noted that there are limitations to applying size criteria
alone to determine the presence of pathology, with studies
showing relatively low sensitivity and specificity for
detection of metastases [38, 39]. In addition, the lower
spatial resolution in MRI may result in closely opposed
lymph nodes being inseparable and appearing as a
larger nodal mass [40].
Further investigations
As with most imaging investigations, the next best investi-
gation when faced with a mediastinal abnormality is to re-
view the last investigation, when present. Increasing
numbers of patients undergoing CMR have had previous
cross-sectional imaging with computed tomography (CT)
which can help determine the aetiology and significance
of mediastinal abnormalities detected at the time of CMR.
If in doubt, the expert opinion of a Radiologist should be
sought.
Lungs and pleura
The standard axial imaging performed at the time of
CMR usually covers most of the thorax. MRI assessment
of the lung parenchyma is often limited by a combin-
ation of respiratory motion artifact, low proton density
of the aerated lung parenchyma and the presence of sus-
ceptibility artifact occurring at air-tissue interfaces [41].
Despite this, significant pulmonary abnormalities are
found in up to 21.8 % of CMR examinations [5].
Normal variant anatomy
A common anatomical variant that should not be con-
fused with pathology is the azygous lobe fissure (Fig. 8).
It has been reported in 1 % of pathological specimens
[42]. It occurs as the displaced azygous vein makes a
deep invagination into the apical segment of the right
upper lobe, carrying with it both pleural layers. As it
lacks its own bronchus, it is not a true anatomical
accessory lobe.
Fig. 6 Axial black blood imaging (a and b) and coronal bright blood imaging (c) demonstrating florid mediastinal adenopathy engulfing the
trachea and proximal main bronchi (solid white arrows) detected incidentally at the time of CMR
Fig. 7 Axial black blood imaging (a) and coronal bright blood imaging (b) acquired during a myocardial and hepatic iron loading protocol CMR
in an individual with thalassaemia major. There are several prominent heterogeneous posterior mediastinal masses (solid white arrows) consistent
with extramedullary haematopoeisis. The liver is uniformly low signal (white *), which is visual evidence of hepatic iron loading in the clinical
context and the spleen is absent (black *) which may be the result of an auto-splenectomy
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Common pathology
Consolidation is not infrequently encountered. Technic-
ally, consolidation is a radiographic term referring to in-
crease in lung parenchymal attenuation that obscures
the vascular margins [43]. It is not specific to infection
and can occur in pulmonary oedema, pulmonary haem-
orrhage and malignancy and they need to be differenti-
ated on the basis of clinical findings.
Smoking is a risk factor for atherosclerosis and lung
malignancy. Many subjects undergoing CMR are at risk
of lung malignancy and the lungs should be reviewed
carefully for lung nodules, defined as a rounded opacities
well or poorly defined measuring ≤ 3 cm in diameter
(Fig. 9a and b), and/or lung masses, defined as a opa-
city > 3 cm in diameter (Fig. 9c and d) [43]. It should be
appreciated that, due to the slice thickness of the axial
and coronal anatomical images, small nodules may not
be discernible at the time of CMR.
Pulmonary embolic disease is a common cause of chest
pain but may also be detected incidentally. Dedicated MR
pulmonary angiographic sequences can detect pulmonary
emboli but are less specific than CT [44]. Nevertheless,
pulmonary emboli may be detectable as abnormal signal
return from the pulmonary arteries on standard axial black
blood and coronal bright blood images (Fig. 10a and b). In
addition, pulmonary emboli may be detectable on late
gadolinium enhancement (LGE) images, with similar im-
aging appearances to ventricular thrombus but within the
pulmonary arterial tree (Fig. 10c). Review for pulmonary
emboli should be performed in patients undergoing CMR
in the context of chest pain, elevated troponin but unob-
structed coronary arteries where a pulmonary embolism
may be the underlying aetiology but if there is clinical con-
cern a CT pulmonary angiogram should be performed.
However, if a pulmonary embolism is detected on CMR,
the cine sequences should be reviewed for intracardiac
thrombus and/or signs of right heart strain. Depending on
the extent of the embolus, there may be associated pul-
monary infarct or pleural effusion.
The most common pleural abnormality identified at
the time of CMR is a pleural effusion. They are usually
Fig. 8 Axial black blood image of the superior mediastinum acquired
at the time of CMR showing a linear high signal entity in the apical
segment of the right upper lobe (solid white arrows) consistent with
an incidental azygous lobe fissure
Fig. 9 Axial black blood imaging (a) revealing an incidental 1.7 cm soft tissue density nodule in the right upper lobe (solid white arrows), which
was subsequently confirmed with CT (b). Axial black blood imaging (c) demonstrating an incidental 3.1 cm soft tissue mass intimately related to
the superior vena cava (solid white arrows), which was subsequently confirmed with CT (d)
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seen layered posteriorly with low T1 and high T2 signal,
although this may be heterogeneous due to flow arte-
facts within.
Important imaging findings
When faced with a lung parenchymal opacity, it is im-
portant to try to measure the maximal dimension of the
entity. MRI has a sensitivity of up to 95 % for pulmonary
nodules measuring 5-10 mm in size [45] and is as accur-
ate as CT in detection of nodules over 1 cm in size [46].
Nodule size is the main predictor of malignancy. In the
National Lung Screening Trial, the positive predictive
value for malignancy of nodules 7-10 mm, 11-20 mm
and 21-30 mm in size on CT were 1.7 %, 11.9 % and
29.7 % respectively [47]. The presence of spiculated mar-
gins is also suggestive of malignancy [48].
Although most pleural effusions encountered will be
simple effusions, it is important to assess for features that
would suggest a complex collection. The presence of locu-
lation and pleural thickening are seen in exudative effu-
sions. Pleural nodularity, circumferential or mediastinal
pleural involvement are suggestive of malignancy [49]. In-
vasion into adjacent mediastinal or chest wall structures
indicate aggressive infection or malignancy. Occasionally,
pleural fluid may become encysted in the horizontal and/
or oblique fissures and may mimic a mass but it should be
readily differentiated on MRI to due fluid, rather than soft
tissue, signal characteristics.
Further investigations
When nodules are detected, a review of any previous im-
aging is essential to establish stability or if growth, over
what time frame. Further evaluation with CT is often re-
quired and if appropriate the nodule can then be followed
up as per the Fleischner Society guidelines [50] (Table 2)
or the new 2015 British Thoracic Society guidelines for
the investigation and management of pulmonary nodules
[51]. If there is a suspicion of malignant nodule or mass,
there should be a low threshold for seeking thoracic Radi-
ology or Respiratory opinion. Urgent referral to the local
lung cancer multidisciplinary meeting would be important
in such cases.
Breast
The mammary tissue is visualized on axial cross sec-
tional imaging at the time of CMR. Indeed, incidental
breast lesions are identified in 0.1-2.5 % of CMR studies
and over 50 % of these lesions are clinically significant
[14–16, 52]. In addition, in women, breast cancer is the
most frequently diagnosed cancer and the leading cause
of cancer deaths on the worldwide scale [53]. However,
there are increasing numbers of breast cancer survivors
and there is a corresponding increase in cardiac imaging,
sometimes with CMR, to assess for cardio-toxic side ef-
fects from some of the chemotherapeutic agents used to
treat the disease. Particular care should be given to the
breast tissue in CMR studies performed in such patients
as they remain at risk of disease recurrence.
Fig. 10 Axial black blood imaging (a) and coronal bright blood imaging (b) demonstrating abnormal signal in the right sided pulmonary arterial
system (solid white arrows). Magnitude late gadolinium enhancement 4-chamber image (c) showing signal void in the pulmonary arteries (solid
white arrows) consistent with in situ thrombus from pulmonary embolic disease
Table 2 The Fleischner society recommendations for the
follow-up and management of solid pulmonary nodules smaller
than 8 mm detected incidentally in persons 35 years of age or
older – adapted from reference [50]
Nodule size: ≤ 4 mm
• Low riska : No follow-up
• High riskb : Follow-up CT at 12 months and if no change, no further
follow-up required
Nodule size: >4 – 6 mm
• Low riska : Follow-up CT at 12 months and if no change, no further
follow-up required
• High riskb : Initial follow-up CT at 6–12 months and then at 18–24
months if no change
Nodule size: >6 – 8 mm
• Low riska : Initial follow-up CT at 6–12 months and then at 18–24
months if no change
• High riskb : Initial follow-up CT at 3–6 months and then at 9–12
and 24 months if no change
Nodule size: >8 mm
• Follow-up CTs at around 3, 9 and 24 months
or
• Dynamic contrast enhanced CT, PET-CT, and/or biopsy
aLow risk patients: minimal or absent history of smoking and / or other know
risk factors
bHigh risk patients: history of smoking or other known risk factors
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Normal variant anatomy
Breast density varies with age with more fibro-fatty re-
placement of glandular tissue in the elderly. Occasion-
ally, this process may be asymmetrical and a focus of
persistent glandular tissue may mimic a breast lesion.
Common pathology
The differential diagnosis for a focal breast lesion (Fig. 11a)
includes breast cyst, fibroadenoma, prominent area of fibro-
cystic change, fat necrosis, phyllodes tumour and, most
concerning, malignancy. The age of the individual affects
the likely aetiology. For example, breast cysts are a common
cause in premenopausal women >40 years old but an infre-
quent cause of breast masses in younger women. Fibro-
adenomas are areas of overgrowth of normal breast
tissue due to hormonal stimulation that are common in
younger women.
Given the high prevalence of breast cancer, mastecto-
mies are not infrequently encountered at CMR (Fig. 11b).
Identifying such abnormality may have important impli-
cations as it implies a history of previous breast cancer,
which may not always be stated in the clinical informa-
tion accompanying the clinical CMR request. In such
patients, the reporting doctor should have a heightened
level of suspicion that lung and/or bony lesions could
represent metastatic disease. Furthermore, lung paren-
chymal abnormality associated with volume loss in the
ipsilateral upper zone may be a result of previous breast
radiotherapy.
Breast implants, inserted for cosmetic or reconstruct-
ive purposes, are occasionally encountered (Fig. 11c).
Implant rupture is a recognized complication and has
received much media coverage in recent years. The high
specificity of MRI at detecting features of rupture means
those reporting MRI studies covering the breast need to
be aware of the imaging features of rupture which can,
albeit infrequently, be an incidental finding. The bright-
blood, T2 weighted sequences are the most valuable in
detecting potential rupture, which is classified as either
intra- or extra-capsular. The most useful feature of an
intra-capsular rupture is the ‘linguine sign’, which are
curvilinear hypointense lines within the hyperintense sil-
icon [54]. Focal invagination between the inner shell and
fibrous capsule is termed the tear-drop sign [54]. Extra-
capsular rupture is difficult to detect without breast ded-
icated MRI with silicon suppressed sequences.
Important imaging findings
When an incidental breast lesion is discovered, the most
important task is to try and positively identify malignant
lesions. Certain loco-regional changes should be sought
which increase the risk of malignancy, such as nipple in-
version and cutaneous thickening. The lymphatic drain-
age of the breast is to the axillary, internal mammary
and supraclavicular lymph node stations. Therefore,
these nodal groups should be scrutinized in patients
with known breast cancer and those where an incidental
breast mass is identified. Nodal imaging features con-
cerning for malignant infiltration include increased cor-
tical thickness, soft tissue infiltration of the fatty hilum,
lobulated shape and large size [55]. The size limits for
abnormal lymph nodes depend on the sensitivity to speci-
ficity ratio desired. A short-axis diameter >5 mm has been
demonstrated to be highly specific for malignant infiltra-
tion [56]. However, as previously discussed, determining
pathological lymphadenopathy should not be made on
size alone, but include morphological assessment too.
It should be noted that MRI is not a replacement for
oncological staging of breast cancer and CT may still be
required. Furthermore, normal breast appearance on
MRI at the time of CMR does not exclude sinister breast
disease and/or breast cancer recurrence.
Further investigations
The information that can be gathered on the breast tissue
from the routinely used CMR sequences is limited. The
incidental breast mass cannot be fully characterized at the
time of CMR and all lesions should be referred to a breast
unit for further assessment, usually with dedicated clinical
history, mammogram and/or ultrasound and tissue diag-
nosis as appropriate. Dedicated breast MRI is a specialized
investigation involving the patient lying prone with
Fig. 11 Axial black blood imaging (a) showing an abnormal, spiculate soft tissue signal mass in the fatty left breast (solid black lesion) detected
incidentally at the time of CMR. Axial black blood imaging (b) showing previous right-sided mastectomy (solid white arrows). Axial black blood
imaging (c) showing bilateral breast prostheses (*)
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dedicated breast coil and dynamic enhancement protocols
and warrants specialized breast Radiologist interpretation.
Liver, biliary tree and pancreas
Whilst the liver may only be partially imaged on the
most inferior aspect of the field of view during dedicated
cardiac MRI, it may be virtually completely imaged in
whole aortic MRI sequences. Knowledge of normal ana-
tomical variants and common hepato-biliary pathology
is, therefore, important.
Normal variant anatomy
Individuals who regularly report congenital heart disease
CMR will routinely assess the available images to determine
abdominal situs, but all CMR imagers should be comfort-
able identifying such anatomical variations (Fig. 12).
Riedel’s lobe is an accessory right lobe of the liver. It is
described as a tongue-like, inferior extension of the right
lobe of liver into the right flank / right iliac fossa, beyond
the right sided inferior costal cartilage [57]. It should not
be confused with a hepatic mass or hepatomegaly.
Common pathology
Simple hepatic cysts are the most common hepatic par-
enchymal abnormality and are frequently encountered in
the extra-cardiac field of view at the time of CMR. They
will have high signal return on T2 weighted sequences
(Fig. 13a and b). Not all cystic lesions in the liver are
simple and the imaging differential diagnosis includes
cystic tumours, parasitic or hydatid cystic disease, and
hepatic abscesses. However, usually the ancillary clinical
information enables the respective pathologies to be dis-
tinguished, with infective causes unlikely to be asymp-
tomatic incidental findings.
Metastatic disease is the most common cause of malig-
nant liver lesions (Fig. 13c and d). Colon, lung, breast and
gastric malignancies have a predilection for metastasizing
to the liver. The differential for focal liver parenchymal le-
sions includes hepatocellular carcinoma, adenomas,
haemangiomas and focal nodular hyperplasia. Support-
ive clinical findings may be relevant in distinguishing
the pathologies, for example hepatocellular carcinoma
usually occurs in cirrhotic livers, whereas hepatic aden-
omas most frequently occur in young women on the
oral contraceptive pill.
Gallstones occur in approximately 10-15 % of the adult
population [58]. Calcified stones will appear as low sig-
nal entities on MRI (Fig. 14). Cholesterol stones may be
high signal on T1 weighted images. However, not every
individual with gallstone disease will be or will become
symptomatic. Gallbladder wall thickening and perichole-
cystic fluid, suggesting cholecystitis, and biliary tree
dilatation, raising the possibility of choledocholithiasis, are
unlikely to be present when gallstone disease is detected
incidentally at CMR, without right upper quadrant pain
and liver function test derangement respectively. However,
sometimes patients are referred for assessment of atypical
chest pain, which has actually been caused by gallstone
disease.
Images of the liver are routinely acquired when asses-
sing for hepatic iron loading with MRI. Even when the
dedicated gradient recall echo sequences required for as-
sessment of liver T2* are not performed, visual assessment
of the liver and spleen may provide useful insights into the
aetiology of an individual with possible cardiomyopathy of
indeterminate cause. The superparamagnetic effect of iron
accumulation in the tissues results in local magnetic field
distortion and shortening of T1 and T2 relaxation times.
This in turn leads to signal loss from the affected organs.
Diffuse low signal in both the liver and spleen raise the
possibility of secondary cause of iron overloading, whereas
low signal in the liver with preserved signal intensity in
the spleen suggests primary hepatic iron deposition dis-
ease such as haemochromatosis.
Fig. 12 Axial black blood imaging (a) and coronal bright blood imaging (b) demonstrating a left-sided liver (white *), right-sided spleen (black *)
and right-sided stomach (solid white arrow). There is also evidence of a right-sided descending thoracic aorta on the axial and coronal images
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The pancreas often undergoes fatty replacement with
age and may appear atrophic. When a lesion is detected,
the most concerning pathology to be excluded is pancre-
atic malignancy. When this occurs in the pancreatic head,
there is often associated obstruction to the biliary tree and
as a result it is unlikely to present incidentally. However,
the differential diagnosis for focal pancreatic lesions is
wide and if a lesion is identified then expert hepatobiliary
radiology opinion is advised in the first instance to
guide further investigation.
Important imaging findings
In terms of extra-cardiac liver parenchymal lesions, the
main concern is trying to distinguish liver metastases
from benign liver lesions. Liver metastases are variable
in their T1 and T2 signal intensities but usually result in
hypo to iso-intense signal on T1 weighted images and
iso to hyper-intense signal on T2 weighted images. Liver
metastases tend to lose signal with increasing T2 weight-
ing, whereas liver cysts and haemangiomas remain bright.
However, metastases with necrotic cores can mimic cysts
in terms of signal characteristics. Often it is not possible
to definitively characterize liver lesions incidentally de-
tected at the time of CMR.
Further investigations
Reviewing any available previous liver imaging can be use-
ful in determining the aetiology and necessity for further
investigation of the lesion in question. Trans-abdominal
ultrasound is a readily available, harmless investigation
that is often recommended as the next investigation to try
to characterize incidental liver lesions further. Entirely
simple appearing liver cysts do not require further investi-
gation. If there are any atypical features (e.g. ill-defined
margins, complex structure, heterogeneous content) and
there is no previous imaging for comparison then seeking
the opinion of a Radiologist and referral for ultrasound
should be considered. Comprehensive hepatic lesions
characterization with MRI is a specialist investigation,
which requires dedicated hepatic sequences and often ne-
cessitates specific contrast agents.
Fig. 13 Axial black blood imaging (a) and coronal bright blood imaging
(b) showing a well-defined low and high signal entity respectively
consistent with a simple liver cyst. Axial black blood imaging (c)
showing ill-defined low signal entity in the right lobe of liver (red
box) which demonstrated features consistent with a metastasis on
contrast enhanced CT (d). There is also a low signal entity in the
vertebral body (blue box) which was confirmed to represent a
sclerotic metastasis on CT (e)
Fig. 14 Axial (a) and coronal (b) bright blood imaging demonstrating a large low signal entity in a fluid-filled viscus in the right upper quadrant
(solid white arrows), consistent with a large uncomplicated calcific gallstone
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Kidneys
Often only the upper poles of the kidneys are visualized
due the constraints of the field of view at the time of CMR.
This can make accurate localization and characterization of
potential renal abnormalities challenging, which may lead
to over-investigation, potential misinterpretation and incor-
rect diagnosis.
Normal variant anatomy
The size of the kidneys in adult subjects is 10 – 12 cm.
There is normally a slight discrepancy in the length of
the kidneys, with the left kidney usually being slightly
larger by approximately 1 centimetre. If the length of the
patient’s kidneys is going to be measured, it is important
that multiplanar reformatted images adjusted to give a
true long-axis image of each individual kidney are used
to avoid recording foreshortened measurements.
There are several anatomical variations in the kidneys
that may mimic pathology. For example, it is not uncom-
mon for the contour of the kidney to be slightly irregular.
This may be simply due to persistent foetal lobulation or a
dromedary hump, the latter is more common in the left
kidney, rather than a parenchymal abnormality. In the
case of anatomical variations, the cortico-medullary dif-
ferentiation will be preserved and the cortical thickness
uniform.
Occasionally, one or both kidneys are not demon-
strated on the axial or coronal images at the time of
CMR. Providing there is no preceding history of neph-
rectomy, this is often due to low-lying kidney(s) or pel-
vic kidney(s). Sometimes, the kidneys are fused in the
midline and fail to ascend out of the lower abdomen
due to the inferior mesenteric artery blocking the path.
This is termed horseshoe kidney (Fig. 15) and is associ-
ated with certain congenital heart diseases.
Another renal anatomical variation that may cause
confusion is the duplex kidney. This occurs when there
is either complete or partial duplication of the renal col-
lecting system within one kidney. In a complete duplex
kidney, the 2 renal pelvicalyceal systems drain via
separate ureters into the bladder. The upper moiety
often inserts ectopically and may be associated with a
distal ureterocoele resulting in urinary obstruction and
hydronephrosis, whereas the insertion site of the lower
moiety ureter is prone to urinary reflux, which may result
in renal scarring.
Common pathology
The most common focal renal pathology identified at
CMR is a renal cyst. Most of these lesions will be simple
benign cysts of no clinical relevance. However, a propor-
tion of cystic renal lesions have malignant potential.
Sometimes the position of renal cysts can mimic other
pathology, for example prominent para-pelvic renal cysts
can sometimes be confused with hydronephrosis (Fig. 16).
It is not uncommon to detect global renal cortical atro-
phy, particularly in elderly subjects with cardiovascular risk
factors. The patient’s renal function should be routinely
Fig. 15 Axial bright blood imaging revealing a horseshoe kidney (*).
The usual ascent of the kidneys out of the pelvis is impeded by the
physical constraint of the inferior mesenteric artery (solid red arrow)
Fig. 16 Coronal bright blood imaging (a) demonstrating a cystic entity at the left renal pelvis (solid white arrows). There is also a simple cortical
renal cyst in the left lower pole. Correlative trans-abdominal ultrasound image (b) revealed the hypoechoic areas at the renal hilum are in continuity
with a dilated proximal ureter and there is calyceal blunting (solid white arrows). These findings are consistent with hydronephrosis rather than
para-pelvic cysts
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checked before CMR and administration of intravenous
gadolinium chelate contrast agent so the discovery of
such renal appearances should not be unexpected to
the referring clinician. Occasionally, unilateral renal
atrophy will be demonstrated. In such cases, it is
worth raising the question of ipsilateral renal artery
stenosis as the cause, which may be amenable to
intervention.
Important imaging findings
The challenge when faced with an incidental renal cystic
lesion is to determine the likely malignant potential. The
size and number of simple cysts are not usually clinical
important in this regard. The latter is only really relevant
in cases of excessive renal cysts, which may raise the pos-
sibility of polycystic kidney disease. The malignant poten-
tial of renal cysts can be predicted using the Bosniak
classification [59] (Table 3). This classification is based on
imaging findings on post-contrast CT but findings are
similar at MRI [60] and therefore the classification can be
loosely extrapolated to incidental cysts found at the time
of CMR. The important message is that completely simple
cysts have virtually no malignant potential but complex
cysts with multiple septations and nodules as well as part-
solid, part-cystic components are highly concerning for
malignancy. Occasionally, renal cysts in the left kidney
will be demonstrated in the field of view of LGE images
(Fig. 17). These images may provide information about
lack of cyst enhancement, which is a reassuring feature.
Differentiating para-pelvic cysts from hydronephrosis
can be challenging. The important ancillary findings that
favour the latter include blunting of the renal calyces
(Fig. 16b) and associated cortical atrophy (but this will
only be present in longstanding obstruction). The pres-
ence of a concomitant dilated ureter, if demonstrated on
the CMR images, also favours obstruction over para-
Table 3 The Bosniak renal cyst classification system – adapted
from reference [59]
Bosniak I
• Simple cyst
o Hairline-thin wall, no septations, no calcifications, no solid
components
o Management: Nil
o Malignant potential: Approximately 0 %
Bosniak II
• Minimally complex
o May contain a few hairline-thin septa with no perceivable
enhancement, fine calcification or short segment of thicker
calcification in wall or septa, or uniformly high-attenuation lesions
on CT <3 cm that are sharply marginated and do not enhance
o Management: Nil
o Malignant potential: Approximately 0 %
Bosniak IIF
• Minimally complex
o Multiple hairline-thin septa, perceived septal enhancement but no
measureable enhancement, minimal wall thickening, calcification
may be thicker and nodular, no enhancing soft tissue components,
or totally intra-renal non-enhancing high-attenuating renal lesions
>3 cm
o Management: Ultrasound or CT follow-up
o Malignant potential: Approximately 5 %
Bosniak III
• Indeterminate
o Thickened irregular or smooth walls or septa with measureable
enhancement
o Management: Partial nephrectomy or radiofrequency ablation
o Malignant potential: Approximately 55 %
Bosniak IV
• Clearly malignant
o All criteria of Bosniak III but also contain discrete enhancing soft
tissue components independent of the wall or septa
o Management: Partial or complete nephrectomy
o Malignant potential: Approximately 100 %
Fig. 17 Short-axis steady state free precession cine image (a) revealing a high signal cyst in the visualized left kidney (solid white arrow). On the
corresponding magnitude late gadolinium enhancement image (b) there is no enhancement of the cyst (solid white arrow) but diffuse
enhancement of the surrounding normal renal parenchyma. This is a reassuring feature of renal cystic lesions
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pelvic cyst (Fig. 16b). It should be noted that para-pelvic
cysts are more likely to be incidental and urinary ob-
struction is more likely to present with corresponding
clinical and biochemical abnormalities.
Further investigations
Before considering additional imaging, it is important to
review any previous renal imaging. Stability in appear-
ances over a long period of time is clearly a reassuring fea-
ture. Ultrasound is a readily available modality that can
help further characterize incidental renal lesions in the
first instance. If there is any concern of urinary obstruc-
tion, an urgent Urological opinion should be sought. It
there are any concerns regarding possible malignant po-
tential of renal cystic lesions or other renal masses, seek
expert uro-radiological input and have a low threshold for
urgent review at the Urology cancer multidisciplinary
team meeting. A contrast enhanced CT study will be
needed to definitively characterize the lesion and stage
any potential disseminated metastatic disease.
Spleen
The spleen is often best visualized in coronal anatomical
imaging sequences, if performed. It may be incompletely
imaged in axial dataset.
Normal variant anatomy
In adults, the normal size of the spleen is between 12 –
15 cm. Care should be taken to ensure measurements are
performed in maximal bipolar dimension (Fig. 18a). Ele-
vated height and increased body mass index are associated
with larger splenic dimensions in otherwise normal spleens.
It is fairly common to encounter rounded, well-
circumscribed soft tissue masses in the left upper
quadrant in the vicinity of the spleen. These are invari-
ably a focus / foci of accessory splenic tissue termed a
splenunculus / splenuculi.
The normal physiology of the spleen should be
understood by individuals who perform adenosine stress
perfusion CMR. The spleen can down-regulate its func-
tion during ‘stress’ with intravenous adenosine which
manifests as lack of enhancement, either assessed visually
Fig. 18 Axial black blood imaging of the upper abdomen (a) revealing splenomegaly, with maximal bipolar diameter of the spleen of 17.1 cm
(solid black arrows). This was detected incidentally at the time of CMR. Scrutinizing the other available extra-cardiac images (b) revealed extensive
mediastinal lymphadenopathy (solid white arrows), suggesting the splenomegaly was due to lymphoma in this patient
Fig. 19 Real-time first pass myocardial perfusion at peak stress following administration of intravenous adenosine (a) revealing no discernible
enhancement of the visualized spleen (solid white arrow). Real-time first pass myocardial perfusion at rest in the same patient (b) revealing normal
diffuse enhancement of the splenic tissue in the field of view (dashed white arrow)
Rodrigues et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:26 Page 14 of 21
or quantitatively, on the stress images relative to the rest
images (Fig. 19) [61]. In addition to heart and blood pres-
sure changes and development of symptoms, the so-called
‘splenic switch-off ’ sign may be another useful marker to
ensure the patient has been adequately stressed during an
adenosine perfusion CMR [61].
Common pathology
Splenomegaly should be assessed as described. There are
numerous causes of splenic enlargement. However, certain
causes of splenomegaly are more likely to be present de-
pending on the indication of the CMR. For example, in pa-
tients being assessed for iron loading, haematological
disorders are the most likely cause of splenomegaly. Con-
gestive splenomegaly may occur in right heart or biven-
tricular heart failure. Viral pathogens may cause both
splenomegaly and viral myocarditis. Amyloidosis and
sarcoidosis are other disorders that may cause con-
comitant cardiac and splenic pathology.
Focal splenic lesions are uncommon. In the case of in-
cidentally detected lesions, they most likely represent
haemangiomata or the sequelae of previous trauma. An
expert radiological opinion should be sought in any un-
certain cases.
Important imaging findings
When splenomegaly is discovered, the available images
should be scrutinized for potential clues to the aetiology
if not already clinical apparent (Fig. 18b).
As with the liver, it is important to assess the signal
characteristics of the spleen. This can help distinguish
between primary and secondary iron overloading condi-
tions as explained in the Liver, Biliary tree and Pancreas
section of this review.
Further investigations
In the context of splenomegaly, further imaging is rarely
additive and the underlying aetiology needs to be deter-
mined clinically. In the case of incidental focal splenic
lesions, reviewing any previous imaging should be the first
step. Ultrasound is often performed as a readily avail-
able and non-ionising radiation modality to further
characterize splenic abnormalities. Discussion with a Radi-
ologist about the necessity for further investigation is then
advised.
Fig. 20 Axial black blood imaging (a) and coronal bright blood imaging (b) revealing an incidental left adrenal nodule (solid black arrow)
detected at the time of CMR
Fig. 21 Axial black blood imaging (a) demonstrating abnormal soft tissue signal masses in the anticipated anatomical location of the adrenal
glands (solid white arrows). These areas were confirmed to be highly metabolically active on metaiodobenzylguanidine (MIBG) study (b)
confirming the diagnosis of bilateral phaeochromocytomas, which were the cause of this patient’s hypertension
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Adrenal glands
The adrenal glands are often visualized on the axial and
coronal anatomical imaging performed at the beginning
of a CMR study.
Normal variant anatomy
On axial and coronal MR images, the right adrenal gland
is located immediately posterior to the inferior vena cava
and superior to the upper pole of the right kidney. It has
a linear, inverted V or Y configuration [62]. The left
adrenal gland is anteromedial to the upper pole of the
kidney and posterior to the pancreas and has a triangu-
lar inverted Y or V configuration [62]. Normal adrenal
glands range from 2 to 6 mm in thickness and from 2 to
4 cm in length [62].
Common pathology
Adrenal masses are occasionally encountered inciden-
tally at the time of CMR (Fig. 20). The differential
diagnosis includes primary and metastatic malignancy as
well as benign entities. It should be appreciated that
abnormal adrenal function can occur in anatomically
normal appearing adrenal glands and biochemical
correlation should be performed if there is any clinical
suspicion. Biochemically active lesions are particularly
important to consider in subjects being investigated with
CMR for hypertensive heart disease as this may repre-
sent a treatable secondary cause of their hypertension
(Fig. 21).
Important imaging findings
When an incidental adrenal lesion is identified, the
important clinical question is whether the abnormality
represents a benign or malignant lesion. The biggest risk
factor for malignancy in an incidental adrenal lesion is a
history of known primary malignancy elsewhere; adrenal
Fig. 22 In-phase MRI image (a) showing a right adrenal lesion (solid white arrow). There is signal drop out (dashed white arrow) on the out-of-
phase MRI sequence (b), confirming the presence of intracellular lipid and making the diagnosis of a benign lipid-rich adenoma
Fig. 23 Axial black blood lesion demonstrating a bony lesion in the
right humeral head (solid white arrow)
Fig. 24 4-Chamber steady state free precession cine showing mitral
valve prolapse with central coaptation defect and a jet of mitral
regurgitation (solid black arrows). There is a marked pectus exacavatum
chest wall deformity (solid white arrow). The unifying diagnosis in this
case was Marfan’s syndrome
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metastases are found in as many as 25 % of patients with
known primary lesions [62]. Common primary sites of
malignancy that frequently metastasise to the adrenals
include lung, colon, breast and pancreatic tumours.
The documentation of macroscopic fat or MRI imaging
features of intracellular lipid are reassuring signs that sig-
nify the lesion represents a lipid-rich benign adenoma. The
lack of demonstrable fat means the lesion may still have
malignant potential. If the adrenal entity is appreciated
whilst the patient is still undergoing CMR, a simple add-
itional in/out phase MRI sequence can be performed to
try to distinguish benign from malignant disease (Fig. 22).
This sequence relies on chemical shift artifact; signal loss
on out-of-phase imaging relative to in-phase imaging con-
firms intracellular lipid and benignity (Fig. 22).
Further investigations
Adrenal lesions can be characterized by adrenal protocol
CT and the decision to use MRI or CT depends on local
availability and the individual patient (ionizing radiation
should be minimized wherever possible, particularly in
the young).
Bones
The thoracic rib cage, thoracic axial skeleton and proximal
humeri (Fig. 23) are routinely imaged at the time of CMR.
Familiarity with common and important osseous path-
ology is important for individuals reporting CMR images.
Normal variant anatomy
Pectus carinatum and pectus excavatum are chest wall
deformities that are occasionally encountered. The latter
is important to recognize as it may account for cardiac
dextroposition and extreme dextroversion. It can also
impinge the right ventricular free wall resulting in appar-
ent regional wall motion abnormalities which are im-
portant to recognize, particularly in CMR studies being
performed for suspected arrhythmogenic right ventricu-
lar cardiomyopathy / dysplasia. The presence of pectus
excavatum (Fig. 24) and other spinal abnormalities, such
as dural ectasia, may help support a unifying underling
diagnosis of Marfan’s syndrome.
It should also be recognized that congenital heart dis-
ease is associated with congenital spinal abnormalities,
such as kypho-scoliosis and hemi-vertebrae, and par-
ticular care should be taken when reporting congenital
Fig. 25 Axial black blood imaging (a) and coronal bright blood imaging (b) showing a high signal entity within a thoracic vertebral body, with
no involvement of the posterior elements (solid white arrows). The patient had previously undergone a thoracic CT (c) and this confirmed the
classic appearance of a benign thoracic haemangioma with central ‘polka dot’ sign (white arrow)
Fig. 26 Axial steady state free precession cine image (a) and main pulmonary artery long-axis stack steady state free precession cine image
(b) revealing an abnormal mass within the spinal canal (solid white arrows) detected incidentally at the time of CMR
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heart disease CMR for concomitant bony anatomical
variations.
Common pathology
Lesions in the thoracic vertebral bodies are occasionally
encountered. Incidental, benign vertebral body haem-
angiomas are a common cause of such lesions (Fig. 25).
However, the bone is a common location for metastatic
disease and bony metastases are an important differen-
tial to consider (Fig. 13c and e).
Other bony abnormalities may be demonstrated de-
pending on the clinical indication of the CMR. For ex-
ample, broken ribs are frequently encountered in subjects
undergoing CMR following successful cardiopulmonary
resuscitation.
Depending on the age of the subject undergoing CMR,
degenerative spinal changes may be very frequently en-
countered. Prominent osteophytes should not be confused
with sinister pathology. Degenerative vertebral body disc
protrusions, also known as Schmorl’s nodes, are also com-
mon. They frequently have a calcific low T1 and T2 signal
rim but are contiguous with vertebral body endplates.
Important imaging findings
The key question when faced with a vertebral body lesion
is: can benign disease be differentiated from malignant dis-
ease on the images available? Haemangiomas are vascular,
fatty benign lesions. They appear bright on both T1 and
T2 weighted images (Fig. 25a and b). Metastastic disease
can be broadly divided into osteoblastic and lytic disease.
Fig. 27 Normal variant anatomy, common pathology, important imaging signs and potential further investigations for extra-cardiac findings
discovered at the time of CMR
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The former usually return low T2 weighted signal but lytic
lesions may return high T2 weighted signal. Importantly,
both osteoblastic and lytic metastases usually return
low T1 weighted signal, which helps distinguish from
haemangiomas. Multiple lesions, abnormal surround-
ing soft tissue, prior malignancy, increasing age and/
or smoking history are factors that would increase the
index of suspicion for metastatic disease. If a potential
metastatic lesion is identified, it is important to assess for
associated vertebral body destruction or collapse and ret-
ropulsion of bony fragments towards the spinal canal.
Benign lesions rarely extend into the posterior elements
(vertebral pedicles, lamina or spinous processes). Posterior
element involvement suggests the lesion may be unstable.
Whenever a potential complication of metastatic spinal
disease is noted, urgent oncological opinion is advised as
urgent radiotherapy may be required.
Degenerative intervertebral disc disease often manifests
as loss of intervertebral disc height. A degenerative disc
should be low signal on T1 and T2 weight imaging. If
there is high intra-disc signal on T2 weighted imaging,
discitis needs to be considered. However, discitis usually
does not present incidentally and constitutional symptoms
are often present and there may be other imaging findings
such as a local inflammatory soft tissue reaction.
Finally, it is good practice to review the spinal canal
and cord as occasionally incidental central neuroaxis le-
sions will be identified (Fig. 26).
Further investigations
Previous comparative CT imaging can be very useful to
reassure the interpreter that the suspected lesion is in fact
a benign, incidental haemangioma. These lesions are
characteristically well-defined, low-attenuation areas with
central ‘polka dot’ appearance due to prominent bony tra-
beculations that can only be visualized with the higher
spatial resolution that CT affords (Fig. 25c). Previous CT
scans may also identify a putative primary lesion in the
case of suspected metastatic disease.
Conclusion
A significant amount of the neck, thorax and upper ab-
domen is imaged at the time of routine clinical CMR.
Extra-cardiac findings are common and an important
proportion of these findings are clinically relevant. Indi-
viduals who report CMR have a professional and ethical
duty to be adequately trained in the interpretation of
extra-cardiac findings or seek the opinion of radiology
colleagues who are so. We have reviewed normal ana-
tomical variants that may mimic pathology, common
extra-cardiac findings and important imaging signs not
to miss when reporting extra-cardiac findings at the time
of CMR (Fig. 27). Correctly interpreting extra-cardiac
findings is beneficial to the patient and can prevent
unnecessary over-investigation whilst ensuring indeter-
minate or potentially important lesions are investigated
appropriately. The diseases affecting the heart also often
have systemic effects and identification of certain extra-
cardiac findings can help with the interpretation of the
primary cardiac question. Our review only touches upon
the imaging findings of a variety of important diseases in
many different organ systems and should not be used as
a replacement to seeking expert Radiological input
where there is uncertainty. It is beyond the scope of this
review to discuss and determine the clinical significance
of extracardiac findings at CMR. Our parting piece of
advice is that the next best investigation is usually
reviewing the last imaging investigation the patient
underwent.
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